Variant report

Variant	nsv983320
Chromosome Location	chr12:49297256-49298066
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:300)
CpG islands
(count:488)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:300 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr12:49297751-49297967	K562	blood:	n/a	n/a
2	BCL3	chr12:49297571-49298130	A549	lung:	n/a	n/a
3	BCLAF1	chr12:49297590-49298116	GM12878	blood:	n/a	n/a
4	BCLAF1	chr12:49297680-49298071	GM12878	blood:	n/a	n/a
5	CBX3	chr12:49297760-49298045	K562	blood:	n/a	n/a
6	CEBPB	chr12:49297164-49297517	A549	lung:	n/a	chr12:49297329-49297340
7	CEBPB	chr12:49297263-49297446	HepG2	liver:	n/a	chr12:49297329-49297340
8	CEBPB	chr12:49297166-49297524	K562	blood:	n/a	chr12:49297329-49297340
9	CEBPB	chr12:49297178-49297581	MCF-7	breast:	n/a	chr12:49297329-49297340
10	CEBPB	chr12:49297164-49297527	IMR90	lung:	n/a	chr12:49297329-49297340
11	CEBPB	chr12:49297175-49297521	HepG2	liver:	n/a	chr12:49297329-49297340
12	CEBPB	chr12:49297233-49297486	H1-hESC	embryonic stem cell:	n/a	chr12:49297329-49297340
13	CHD2	chr12:49297786-49298006	GM12878	blood:	n/a	n/a
14	CREB1	chr12:49297775-49298055	A549	lung:	n/a	n/a
15	CREB1	chr12:49297769-49298016	H1-hESC	embryonic stem cell:	n/a	n/a
16	CTCF	chr12:49297260-49297410	GM12869	blood:	n/a	n/a
17	CTCF	chr12:49297806-49297928	Hela-S3	cervix:	n/a	n/a
18	CTCF	chr12:49297420-49297570	GM12871	blood:	n/a	n/a
19	CTCF	chr12:49297494-49297658	GM10248	blood:	n/a	n/a
20	CTCF	chr12:49297535-49297625	GM10266	blood:	n/a	n/a
21	CTCF	chr12:49297752-49297988	NHEK	skin:	n/a	n/a
22	CTCF	chr12:49297780-49297930	HMEC	breast:	n/a	n/a
23	CTCF	chr12:49297703-49298106	A549	lung:	n/a	n/a
24	CTCF	chr12:49297725-49297987	GM19240	blood:	n/a	n/a
25	CTCF	chr12:49297760-49297910	BE2_C	brain:	n/a	n/a
26	CTCF	chr12:49297780-49297930	GM12871	blood:	n/a	n/a
27	CTCF	chr12:49297742-49297956	GM10266	blood:	n/a	n/a
28	CTCF	chr12:49297740-49297890	A549	lung:	n/a	n/a
29	CTCF	chr12:49297360-49297510	GM12874	blood:	n/a	n/a
30	CTCF	chr12:49297360-49297510	WI-38	lung:	n/a	n/a
31	CTCF	chr12:49297400-49297550	GM12873	blood:	n/a	n/a
32	CTCF	chr12:49297780-49297930	GM12872	blood:	n/a	n/a
33	CTCF	chr12:49297780-49297930	HEK293	kidney:	n/a	n/a
34	CTCF	chr12:49297460-49297610	GM12867	blood:	n/a	n/a
35	CTCF	chr12:49297800-49297950	HepG2	liver:	n/a	n/a
36	CTCF	chr12:49297268-49297303	GM10266	blood:	n/a	n/a
37	CTCF	chr12:49297758-49297994	Gliobla	brain:	n/a	n/a
38	CTCF	chr12:49297554-49298117	K562	blood:	n/a	n/a
39	CTCF	chr12:49297720-49297870	WI-38	lung:	n/a	n/a
40	CTCF	chr12:49297629-49298024	K562	blood:	n/a	n/a
41	CTCF	chr12:49297760-49297910	GM12873	blood:	n/a	n/a
42	CTCF	chr12:49297739-49297966	Kidney_OC	kidney:	n/a	n/a
43	CTCF	chr12:49297780-49297930	GM12874	blood:	n/a	n/a
44	CTCF	chr12:49297760-49297910	AoAF	blood vessel:	n/a	n/a
45	CTCF	chr12:49297528-49298306	SK-N-SH	brain:	n/a	n/a
46	CTCF	chr12:49297732-49298007	GM12878	blood:	n/a	n/a
47	CTCF	chr12:49297780-49297930	AG04450	lung:	n/a	n/a
48	CTCF	chr12:49297780-49297930	GM12869	blood:	n/a	n/a
49	CTCF	chr12:49297780-49297930	HEEpiC	esophagus:	n/a	n/a
50	CTCF	chr12:49297752-49297946	HepG2	liver:	n/a	n/a

(count:488 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:49297974-49298024	HUVEC	blood vessel:	n/a
2	chr12:49297824-49297874	GM06990	blood:	n/a
3	chr12:49297846-49297896	ovcar-3	ovarian:	n/a
4	chr12:49297974-49298024	HRPEpiC	eye:	n/a
5	chr12:49297541-49297591	H1-hESC	embryonic stem cell:	embryo
6	chr12:49297569-49297619	PrEC	prostate:	n/a
7	chr12:49297974-49298024	RPTEC	kidney:	n/a
8	chr12:49297901-49297951	NHDF-neo	bronchial:	n/a
9	chr12:49297569-49297619	CMK	blood:	n/a
10	chr12:49297569-49297619	A549	lung:	n/a
11	chr12:49297569-49297619	H1-hESC	embryonic stem cell:	embryo
12	chr12:49297901-49297951	GM12878	blood:	n/a
13	chr12:49297824-49297874	HAEpiC	amniotic membrane:	n/a
14	chr12:49297569-49297619	HCT-116	colon:	n/a
15	chr12:49297508-49297558	RPTEC	kidney:	n/a
16	chr12:49297846-49297896	HL-60	blood:	n/a
17	chr12:49297974-49298024	SK-N-MC	brain:	n/a
18	chr12:49297824-49297874	GM12878	blood:	n/a
19	chr12:49297901-49297951	HCPEpiC	choroid plexus:	n/a
20	chr12:49297541-49297591	AG10803	skin:	n/a
21	chr12:49297822-49297872	Hepatocyte	liver:	n/a
22	chr12:49297541-49297591	NT2-D1	testis:	n/a
23	chr12:49297822-49297872	AG09309	skin:	n/a
24	chr12:49297541-49297591	HNPCEpiC	eye:	n/a
25	chr12:49297569-49297619	MCF-7	breast:	n/a
26	chr12:49297508-49297558	HL-60	blood:	n/a
27	chr12:49297822-49297872	Hela-S3	cervix:	n/a
28	chr12:49297846-49297896	HRPEpiC	eye:	n/a
29	chr12:49297846-49297896	HMEC	breast:	n/a
30	chr12:49297824-49297874	Jurkat	blood:	n/a
31	chr12:49297824-49297874	U87	brain:	n/a
32	chr12:49297541-49297591	AoSMC	blood vessel:	n/a
33	chr12:49297974-49298024	ProgFib	skin:	n/a
34	chr12:49297846-49297896	GM06990	blood:	n/a
35	chr12:49297824-49297874	NHDF-neo	bronchial:	n/a
36	chr12:49297974-49298024	IMR90	lung:	fetal
37	chr12:49297569-49297619	Hepatocyte	liver:	n/a
38	chr12:49297569-49297619	NHBE	bronchial:	n/a
39	chr12:49297901-49297951	AG04450	lung:	fetal
40	chr12:49297974-49298024	ovcar-3	ovarian:	n/a
41	chr12:49297508-49297558	SK-N-MC	brain:	n/a
42	chr12:49297901-49297951	AG04449	skin:	fetal
43	chr12:49297541-49297591	MCF-7	breast:	n/a
44	chr12:49297974-49298024	HCPEpiC	choroid plexus:	n/a
45	chr12:49297974-49298024	Hela-S3	cervix:	n/a
46	chr12:49297846-49297896	HUVEC	blood vessel:	n/a
47	chr12:49297541-49297591	PrEC	prostate:	n/a
48	chr12:49297974-49298024	Jurkat	blood:	n/a
49	chr12:49297901-49297951	NB4	blood:	n/a
50	chr12:49297974-49298024	NT2-D1	testis:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:49207912..49209568-chr12:49296260..49299188,2	K562	blood:
2	chr12:49258108..49259713-chr12:49297461..49298990,2	MCF-7	breast:
3	chr12:49258556..49260730-chr12:49298046..49299547,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000239617	TF binding region
CCDC65	TF binding region
ENSG00000239617	CpG island
CCDC65	CpG island
ENSG00000167535	chromatin interactions
ENSG00000172602	chromatin interactions

Extended variants
information (count: 41 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:41 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs190131204	chr12:49297283-49297284	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs182366187	chr12:49297359-49297360	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs187461726	chr12:49297364-49297365	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs560800227	chr12:49297375-49297376	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs193046531	chr12:49297383-49297384	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs539810659	chr12:49297401-49297402	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs560435338	chr12:49297410-49297411	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs532621682	chr12:49297434-49297435	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs552506927	chr12:49297465-49297466	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs563143031	chr12:49297500-49297501	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs12825285	chr12:49297533-49297534	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs531789374	chr12:49297561-49297562	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs369733963	chr12:49297629-49297630	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs568426785	chr12:49297653-49297654	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs3926119	chr12:49297677-49297678	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs185114210	chr12:49297690-49297691	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs547764323	chr12:49297694-49297695	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs566780984	chr12:49297708-49297709	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs369628680	chr12:49297718-49297719	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs4018506	chr12:49297720-49297721	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs571837779	chr12:49297721-49297722	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs35085441	chr12:49297728-49297729	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs35930424	chr12:49297767-49297768	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs143637622	chr12:49297769-49297770	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs1318692	chr12:49297785-49297786	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
26	rs189176370	chr12:49297791-49297792	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs73302125	chr12:49297813-49297814	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs113888388	chr12:49297818-49297819	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs574168037	chr12:49297838-49297839	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs961320	chr12:49297864-49297865	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
31	rs369773697	chr12:49297904-49297905	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs146783875	chr12:49297932-49297933	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs553313174	chr12:49297936-49297937	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs576422604	chr12:49297941-49297942	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs546504069	chr12:49297956-49297957	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs563024156	chr12:49297957-49297958	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs531948012	chr12:49297985-49297986	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs542028640	chr12:49298033-49298034	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs562164780	chr12:49298035-49298036	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs3809147	chr12:49298059-49298060	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
41	rs74088529	chr12:49298061-49298062	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:69)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Seminomas	18059402	CNVD
Wilms tumour	21544195	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Neurodevelopmental disorder	22521361	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Hirschsprung''s Disease	21712996	CNVD
Lissencephaly	21572526	CNVD
Lung cancer	18438408	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Breast cancer	19602461	CNVD
Breast cancer	17899364	CNVD
Colorectal cancer	16272173	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	18632612	CNVD
Follicular lymphoma	20505157	CNVD
Hepatocellular carcinoma	16750200	CNVD
Melanoma	18172304	CNVD
Metanephric adenoma	20802469	CNVD
Glioblastoma multiforme	17387387	CNVD
liposarcomas	17372913	CNVD
Non-small cell lung cancer	24170126	CNVD
Cancer	16751803	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Bladder cancer	21909424	CNVD
Multiple myeloma	16616336	CNVD
Intracranial aneurysm	16715129	CNVD
Breast cancer	17661082	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	21785460	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Intracranial ependymoma	16609018	CNVD
Cancer	17160897	CNVD
Breast cancer	22522925	CNVD
Cancer	20164919	CNVD

Chromatin state (count:218 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:49293200-49297400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
2	chr12:49295200-49297400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
3	chr12:49295400-49297400	Weak transcription	Fetal Intestine Large	intestine
4	chr12:49296800-49298000	Weak transcription	Lung	lung
5	chr12:49297000-49297400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
6	chr12:49297000-49297800	Bivalent Enhancer	Primary T cells from cord blood	blood
7	chr12:49297200-49297400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr12:49297200-49297400	Enhancers	Primary monocytes fromperipheralblood	blood
9	chr12:49297200-49297400	Flanking Active TSS	Primary hematopoietic stem cells	blood
10	chr12:49297200-49297400	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
11	chr12:49297200-49297400	Enhancers	Adipose Nuclei	Adipose
12	chr12:49297200-49297400	Active TSS	Fetal Intestine Small	intestine
13	chr12:49297200-49297400	Flanking Bivalent TSS/Enh	Placenta	Placenta
14	chr12:49297200-49297400	Enhancers	Pancreas	Pancrea
15	chr12:49297200-49297400	Enhancers	GM12878-XiMat	blood
16	chr12:49297200-49297400	Flanking Active TSS	HepG2	liver
17	chr12:49297200-49297400	Enhancers	HUVEC	blood vessel
18	chr12:49297200-49297600	Enhancers	HUES6 Cell Line	embryonic stem cell
19	chr12:49297200-49297600	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
20	chr12:49297200-49297600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
21	chr12:49297200-49297600	Flanking Active TSS	Duodenum Mucosa	Duodenum
22	chr12:49297200-49297600	Flanking Active TSS	A549	lung
23	chr12:49297200-49297600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
24	chr12:49297200-49297800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
25	chr12:49297200-49297800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
26	chr12:49297200-49297800	Enhancers	Primary T cells fromperipheralblood	blood
27	chr12:49297200-49297800	Enhancers	Primary T helper naive cells from peripheral blood	blood
28	chr12:49297200-49297800	Enhancers	Primary T helper cells PMA-I stimulated	--
29	chr12:49297200-49297800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
30	chr12:49297200-49297800	Enhancers	Fetal Muscle Leg	muscle
31	chr12:49297200-49297800	Enhancers	Left Ventricle	heart
32	chr12:49297200-49298400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
33	chr12:49297200-49298400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
34	chr12:49297200-49298400	Active TSS	Brain Substantia Nigra	brain
35	chr12:49297400-49297600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
36	chr12:49297400-49297600	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr12:49297400-49297600	Flanking Active TSS	Adipose Nuclei	Adipose
38	chr12:49297400-49297600	Flanking Active TSS	Fetal Intestine Large	intestine
39	chr12:49297400-49297600	Flanking Active TSS	Placenta	Placenta
40	chr12:49297400-49297600	Flanking Active TSS	Pancreas	Pancrea
41	chr12:49297400-49297600	Flanking Bivalent TSS/Enh	Stomach Smooth Muscle	stomach
42	chr12:49297400-49297600	Flanking Active TSS	GM12878-XiMat	blood
43	chr12:49297400-49297600	Flanking Active TSS	HUVEC	blood vessel
44	chr12:49297400-49297800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
45	chr12:49297400-49297800	Enhancers	Primary B cells from peripheral blood	blood
46	chr12:49297400-49297800	Enhancers	Primary hematopoietic stem cells	blood
47	chr12:49297400-49297800	Enhancers	Primary hematopoietic stem cells short term culture	blood
48	chr12:49297400-49297800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
49	chr12:49297400-49297800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
50	chr12:49297400-49297800	Enhancers	Primary T helper cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links